Cholangitis screening: Difference between revisions
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no accepted screening programs for [[cholangitis]] or [[cholangiocarcinoma]], a cancer associated with this disease. Methods do exist to detect the early onset of both diseases, though. | There are no accepted screening programs for [[cholangitis]] or [[cholangiocarcinoma]], a cancer associated with this disease. Methods do exist to detect the early onset of both diseases, though. | ||
==Screening== | ==Screening== | ||
Revision as of 20:05, 13 September 2016
|
Cholangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangitis screening On the Web |
|
American Roentgen Ray Society Images of Cholangitis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farwa Haideri [2]
Overview
There are no accepted screening programs for cholangitis or cholangiocarcinoma, a cancer associated with this disease. Methods do exist to detect the early onset of both diseases, though.
Screening
Cancer predominantly associated with cholangitis include cholangiocarcinoma. There are no accepted screening programs for either disease. However, methods for detecting early onsets of cholangitis and cholangiocarcinoma include using biochemical markers, scanning using positron emission tomography or MRI and endoscopic procedures such as endosonography and endoscopic retrograde cholangiopancreatography.[1]
References
- ↑ Kitiyakara T, Chapman RW (2008). "Chemoprevention and screening in primary sclerosing cholangitis". Postgrad Med J. 84 (991): 228–37. doi:10.1136/pgmj.2007.064592. PMID 18508979.